Salona Global Medical Device Corporation
Evome Medical Technologies Inc. designs, develops, produces, and sells medical devices in the United States. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. The company is based in Shirley, New York.
Salona Global Medical Device Corporation (LNDZF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: -0.521x
Based on the latest financial reports, Salona Global Medical Device Corporation (LNDZF) has a cash flow conversion efficiency ratio of -0.521x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.79 Million) by net assets ($-3.43 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Salona Global Medical Device Corporation - Cash Flow Conversion Efficiency Trend (2014–2023)
This chart illustrates how Salona Global Medical Device Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Salona Global Medical Device Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Salona Global Medical Device Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
RightBridge Ventures Group AB
ST:RIGHTB
|
0.172x |
|
Heart Test Laboratories Inc. Warrant
NASDAQ:HSCSW
|
-558.107x |
|
NRSA
STU:NRSA
|
N/A |
|
AJ Bell plc
LSE:AJB
|
0.252x |
|
National Rural Utilities Cooperative Finance Corp
NYSE:NRUC
|
N/A |
|
TRINITY IND
BE:TTA
|
0.060x |
|
Wealth Inv OptiAct and Indx KL
CO:WEIOAI
|
N/A |
|
ELECTRIC POWER DEVL
MU:FJG
|
N/A |
Annual Cash Flow Conversion Efficiency for Salona Global Medical Device Corporation (2014–2023)
The table below shows the annual cash flow conversion efficiency of Salona Global Medical Device Corporation from 2014 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $4.00 Million | $-918.91K | -0.230x | -254.37% |
| 2022-12-31 | $15.33 Million | $-993.08K | -0.065x | +77.00% |
| 2021-12-31 | $13.15 Million | $-3.70 Million | -0.282x | -91.79% |
| 2020-12-31 | $6.64 Million | $-975.17K | -0.147x | -928.06% |
| 2019-12-31 | $8.97 Million | $-128.05K | -0.014x | -104.00% |
| 2018-12-31 | $11.21 Million | $4.00 Million | 0.357x | +28.08% |
| 2017-12-31 | $11.04 Million | $3.08 Million | 0.279x | +54.63% |
| 2016-12-31 | $19.67 Million | $3.54 Million | 0.180x | +125.57% |
| 2015-12-31 | $29.38 Million | $-20.70 Million | -0.705x | -676.96% |
| 2014-12-31 | $6.58 Million | $803.82K | 0.122x | -- |